BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21566450)

  • 1. [A case of toxicity caused by drug interaction between capecitabine and phenytoin in patient with colorectal cancer].
    Sakurai M; Kawahara K; Ueda R; Fukui E; Yamada R
    Gan To Kagaku Ryoho; 2011 May; 38(5):841-3. PubMed ID: 21566450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of capecitabine therapy on the blood levels of antiepileptic drugs - report of two cases].
    Tanaka H; Jotoku H; Takasaki M; Ibayashi Y; Watanabe K; Takahashi M
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):527-30. PubMed ID: 24743375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports.
    Brickell K; Porter D; Thompson P
    Br J Cancer; 2003 Aug; 89(4):615-6. PubMed ID: 12915866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of phenytoin intoxication caused by interaction between phenytoin and capecitabine].
    Taguchi Y; Takashima S; Tanaka K
    Brain Nerve; 2015 Feb; 67(2):213-7. PubMed ID: 25681367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine-phenytoin interaction is dose dependent with an unexpected time course.
    Privitera M; de Los Ríos la Rosa F
    Anticancer Drugs; 2011 Nov; 22(10):1027-9. PubMed ID: 21909021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myocardial ischaemia as a result of treatment with capecitabine].
    van Halteren HK; Liem AH; Planting AS
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1469-73. PubMed ID: 17633978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of capecitabine and phenytoin may cause phenytoin intoxication: a case report.
    Ciftci R; Tas F; Karabulut S; Ciftci S
    Am J Ther; 2015; 22(1):e17-9. PubMed ID: 23689092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid and simple HPLC assay for quantification of capecitabine for drug monitoring purposes.
    Farkouh A; Ettlinger D; Schueller J; Georgopoulos A; Scheithauer W; Czejka M
    Anticancer Res; 2010 Dec; 30(12):5207-11. PubMed ID: 21187514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine in the management of colorectal cancer.
    Maroun JA
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):327-33. PubMed ID: 12113099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
    Aprile G; Mazzer M; Moroso S; Puglisi F
    Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin toxicity as a result of 5-fluorouracil administration.
    Rosemergy I; Findlay M
    N Z Med J; 2002 Aug; 115(1159):U124. PubMed ID: 12362168
    [No Abstract]   [Full Text] [Related]  

  • 12. [The prevention of diarrhea while under capecitabine therapy].
    Grouls V
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1750. PubMed ID: 18696410
    [No Abstract]   [Full Text] [Related]  

  • 13. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenytoin and fluorouracil interaction.
    Gilbar PJ; Brodribb TR
    Ann Pharmacother; 2001 Nov; 35(11):1367-70. PubMed ID: 11724084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemoradiation for locally advanced rectal cancer with capecitabine 2,000 mg/m2/day.
    Veerasarn V; Boonnuch W; Chinswangwatanakul V; Lohsiriwat D; Mahamadsolaeh P
    J Med Assoc Thai; 2008 Oct; 91(10):1583-8. PubMed ID: 18972903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal drug-drug interaction of brivudine and capecitabine.
    Rätz Bravo AE; Hofer S; Krähenbühl S; Ludwig C
    Acta Oncol; 2009; 48(4):631-3. PubMed ID: 19165642
    [No Abstract]   [Full Text] [Related]  

  • 17. Capecitabine in the treatment of colorectal cancer.
    Kelly C; Cassidy J
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):803-10. PubMed ID: 17555390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a study of the Multidisciplinary Oncology Group on Gastrointestinal Tumors.
    Petrioli R; Pascucci A; Francini E; Marsili S; Fiaschi AI; Civitelli S; Tanzini G; Battistelli S; Lorenzi M; Roviello F; Francini G;
    Anticancer Drugs; 2008 Jan; 19(1):91-6. PubMed ID: 18043134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
    Lee JJ; Kim TM; Yu SJ; Kim DW; Joh YH; Oh DY; Kwon JH; Kim TY; Heo DS; Bang YJ; Kim NK
    Jpn J Clin Oncol; 2004 Jul; 34(7):400-4. PubMed ID: 15342667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects.
    Stathopoulos GP; Koutantos J; Lazaki H; Rigatos SK; Stathopoulos J; Deliconstantinos G
    Anticancer Res; 2007; 27(3B):1653-6. PubMed ID: 17595791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.